Literature DB >> 20930857

Intravitreal Ranibizumab in the treatment of choroidal neovascularisation secondary to ocular toxocariasis in a 13-year-old boy.

D A M Lyall, B M Hutchison, A Gaskell, M Varikkara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20930857     DOI： 10.1038/eye.2010.131

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.

Authors:  Georgios Makragiannis; Kaveh Vahdani; Ester Carreño; Richard W J Lee; Andrew D Dick; Adam H Ross
Journal:  Int Ophthalmol       Date:  2017-03-30       Impact factor: 2.031

2.  Toxocara polymerase chain reaction on ocular fluids in bilateral granulomatous chorioretinitis.

Authors:  Jenny Xue Tian; Stephen O'Hagan
Journal:  Int Med Case Rep J       Date:  2015-05-18

3.  A Case Report of Intravitreal Dexamethasone Implant with Exudative Retinal Detachment for Ocular Toxocariasis Treatment.

Authors:  Youran Cai; Ye Yang; Xin Zhong
Journal:  Korean J Parasitol       Date:  2022-04-20       Impact factor: 1.341

Review 4.  Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention.

Authors:  Seong Joon Ahn; Na-Kyung Ryoo; Se Joon Woo
Journal:  Asia Pac Allergy       Date:  2014-07-29

Review 5.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.

Authors:  Aniruddha Agarwal; Alessandro Invernizzi; Rohan Bir Singh; William Foulsham; Kanika Aggarwal; Sabia Handa; Rupesh Agrawal; Carlos Pavesio; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.